Investigation of TGFβ1-Induced Long Noncoding RNAs in Endothelial Cells. (10th April 2016)

• Record Type: Journal Article
• Authors: Singh, Krishna K.; Matkar, Pratiek N.; Quan, Adrian; Mantella, Laura-Eve; Teoh, Hwee; Al-Omran, Mohammed; Verma, Subodh
• Other Names: Dumont Aaron S. Academic Editor.
• Is Part Of: International journal of vascular medicine. Volume 2016(2016)
• Publication Date: 2016-04-10
• Subjects: Blood-vessels -- Diseases -- Periodicals; 616.13005
• DOI: 10.1155/2016/2459687
• Languages: English
• ISSNs: 2090-2824

Abstract

Abstract : Objective . To evaluate the relationship between TGF β signaling and endothelial lncRNA expression. Methods. Human umbilical vein endothelial cell (HUVECs) lncRNAs and mRNAs were profiled with the Arraystar Human lncRNA Expression Microarray V3.0 after 24 hours of exposure to TGF β 1 (10 ng/mL). Results . Of the 30, 584 lncRNAs screened, 2, 051 were significantly upregulated and 2, 393 were appreciably downregulated (P < 0.05 ) in response to TGF β . In the same HUVEC samples, 2, 148 of the 26, 106 mRNAs screened were upregulated and 1, 290 were downregulated. Of these 2, 051 differentially expressed upregulated lncRNAs, MALAT1, which is known to be induced by TGF β in endothelial cells, was the most (~220-fold) upregulated lncRNA. Bioinformatics analyses indicated that the differentially expressed upregulated mRNAs are primarily enriched in hippo signaling, Wnt signaling, focal adhesion, neuroactive ligand-receptor interaction, and pathways in cancer. The most downregulated are notably involved in olfactory transduction, PI3-Akt signaling, Ras signaling, neuroactive ligand-receptor interaction, and apoptosis. Conclusions. This is the first lncRNA and mRNA transcriptome profile of TGF β -mediated changes in human endothelial cells. These observations may reveal potential new targets of TGF β in endothelial cells and novel therapeutic avenues for cardiovascular disease-associated endothelial dysfunction.